Samuel Mitja RapoportHector R. WongHeather A McCauleyMatthew PropstAndrew D. HersheyJennifer McAllisterYan-Shan DaiEric S. HallRonald TaylorBrian WeissWynn G. HunterRaphael KopanKatherine E. YutzeyLaura B RamseyKim M. CecilCharles T QuinnTiffany A CookEnrico D'AnielloGurjit Khurana HersheyEric B. BrandtTheresa W. GuilbertJeremy KinderDevon L. GrahamMichael T. WilliamsPeter De BlankElana HarrisAtsuyasu SatoTodd ArthurLeah C. KottyanLisa J. MartinH. Leighton GrimesDavy VanhoutteLindsey E Romick-RosendaleDonald L. GilbertAkihiro AsaiNehal A ParikhTheodosia A. KalfaGengqiang XieCharles V VorheesJohn S Hutton
P108
P1416
P20
A 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X SyndromeConditioning SCID Infants Diagnosed EarlyFlourish™ Pediatric Esophageal AtresiaBrain Mechanisms of Juvenile FibromyalgiaTeaching Academic Success Skills to Students With Autism Spectrum Disorders in Clinical SettingPembro + Blina Combination in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Leukemia or LymphomaUse of Mometasone Eluting Stent in Choanal AtresiaA Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi AnemiaSafety of LAIV4 in Children With AsthmaRare CFTR Mutation Cell Collection Protocol (RARE)A Study to Assess the Safety, Pharmacodynamics, and Immunogenicity of PXVX0047Safety and Efficacy of Diacerein 1% Ointment Topical Formulation Compared to Placebo for Subjects With Epidermolysis Bullosa Simplex (EBS)N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant NeuroblastomaDose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas AeruginosaAn Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher DiseaseOpen-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic EsophagitisA Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform NeurofibromasComparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome--Pediatric Heart NetworkA Study of Flovent in Patients With Eosinophilic EsophagitisTG4040 in Patients With Chronic HCVBracing in Adolescent Idiopathic Scoliosis Trial (BrAIST)Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal ImagingTrial of Early Aggressive Drug Therapy in Juvenile Idiopathic ArthritisClofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaCombination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid LeukemiaAn Epidemiological Study to Evaluate the RSV-Associated Lower Respiratory Track in Infections in InfantsEvaluation of Mineral Absorption in Infants Fed Infant FormulaHybrid Immunotherapy for Hemophagocytic LymphoHistiocytosisA Study to Evaluate the Mode of Administration and Safety of EUR-1008 (APT-1008) in Infants 1 to 12 Months of AgeMaintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed EpendymomaStudy to Evaluate the Safety, Efficacy and Pharmacokinetics of Optimark (Gadoversetamide) in Pediatric PatientsEverolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaInhaled Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Hereditary Pulmonary Alveolar Proteinosis (PAP)Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious PubertyA Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of RetinoblastomaEvaluate Initial Safety of the HemiBridge™ System in Guided Spinal Growth Treatment of Progressive Idiopathic ScoliosisSunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or EpendymomaHaplo T-Cell Depleted Transplantation in High-Risk Sickle Cell DiseaseSorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
P6153
Q110415-fc0ad4e6-4f8b-d504-9dff-460c9cb0d0cfQ37371526-548FCF3C-4B7C-4F11-950E-82D0700AB147Q38544576-45794BC3-F5C1-49FD-83F9-4C177CAE01D6Q38544835-E4014336-E22C-40B1-BAA1-AC340050E8EEQ38642589-06C0BA5A-3FA1-4E1E-88A7-CFC814B6BFD8Q39636709-43E4541C-7A68-4E81-A9FE-097EEF629F7DQ39752729-842CC290-D614-47A5-A4D7-1F0F312C24D4Q41022099-C542AB01-1551-47A9-9E14-D25CDA8DD8B2Q41048978-374F7AA3-21C8-4302-B3AD-53F221FAA888Q41499529-877846E1-6534-4EA7-9E9A-D7EAE7A8587BQ41652890-8788F461-1A7E-48BB-A074-A9BE0596BD10Q41898306-5B073C89-6544-4ADB-A88F-22530820B6D9Q42128265-66E922C4-522B-4EC4-9D2D-A4DFA2FA893EQ42187542-181AA94D-863E-4C8E-80EB-A3A731E7B488Q42363206-B9CE788B-5A79-4433-A12C-085D7C5130D5Q42365105-D76F8B10-69B1-40F1-8403-218C032E8E2EQ42388913-A7750F57-6728-4CC2-BCB9-AF0CE4D71BBEQ42427825-CC8BBA33-CE5A-455E-A24D-33EAF6180E06Q42707046-DDF78A5B-6204-4A92-A7CA-C83F4C7E72E2Q42739929-2AD3147E-46A1-4564-A930-3E703AF6C96DQ42755645-5CDCDA8B-A2C7-4774-A0DE-06DBFE4DB0EEQ42760645-7E64114B-A2DD-497F-90DA-339D0359B7E5Q42788917-CC1C5315-A982-4730-9DAC-3AA546BBBB06Q42788926-041546C0-5EA1-4FC1-93A0-07DB22906C5FQ42853132-9919D5FD-281C-4E5A-B42C-B213951420A7Q42921377-AC543E78-9926-425D-A5B3-A0914230E614Q43171422-CF9A7B4D-B7E5-408B-86D2-739A65DA9C30Q43174809-0C91E32C-E564-4874-B5AF-E2B75BB31804Q43179315-66785FC2-B936-4B82-B457-F83D6736B8B3Q43179322-2E72EAF2-6FF4-4342-8650-FC3B7C317089Q43184681-5E80725C-89B4-4C4E-B231-FC2E10314FE5Q43228887-81FAC8DA-ACA9-41C6-94F8-AB2492017A59Q43273719-46339D90-E577-41E5-AF76-3ED10D44F4DEQ43296255-B93B039C-9D67-4228-8396-5C3725A18C4DQ45354196-808E4DAD-6455-4F54-B0BA-2BEE47542F07Q46638552-FEDB849E-F13E-4057-AF7B-36C4B04A8D4CQ47100638-03F21F1C-2ADA-4401-AEC1-BD2CB8AEF7DBQ47503348-1F2AAC65-61AD-4A38-A9F5-58C9EF56F5F2Q47572850-69655506-1835-4874-9DC0-11E7B454E022Q47705148-8E927BA3-6AB3-4A9A-A870-3BB01FC8BEB2
P108
description
Krankenhaus
@de
griya sakit
@jv
hospital d'Estaos Xuníos
@ast
hospital in Ohio, United States
@en
hôpital
@fr
rumah sakik
@min
rumah sakit di Amerika Serikat
@id
rumoh sakét
@ace
ziekenhuis in Ohio, Verenigde Staten van Amerika
@nl
בית חולים בארצות הברית
@he
name
Cincinnati Children's Hospital Medical Center
@en
辛辛那提市兒童醫院醫學中心
@zh
type
label
Cincinnati Children's Hospital Medical Center
@en
辛辛那提市兒童醫院醫學中心
@zh
altLabel
Cincinnati Children's
@en
辛辛那提兒童醫院醫療中心
@zh
prefLabel
Cincinnati Children's Hospital Medical Center
@en
辛辛那提市兒童醫院醫學中心
@zh
P1278
P214
P244
P3153
P6366
P1278
549300EKVCKSAOOWU002
P131
P213
0000 0000 9025 8099
P214
P2427
grid.239573.9
P244
no2008095354
P3153
P3417
Cincinnati-Childrens-Hospital-Medical-Center-1
P370
emergency:Yes
P571
1883-01-01T00:00:00Z
P625
Point (-84.502 39.141)
P6366
1285204247